Creo Medical Group (CREO)

Sector:

Health Care

Index:

FTSE AIM All-Share

10.63p
   
  • Change Today:
      0.48p
  • 52 Week High: 19.75
  • 52 Week Low: 9.55
  • Currency: UK Pounds
  • Shares Issued: 412.47m
  • Volume: 827,214
  • Market Cap: £43.83m
  • Beta: 0.52

Latest Deals

Traded Action Notifier PriceAmountValue
08-Aug-25 Transfer To Richard John Rees 0.000p 362,408 £0.00
22-Jul-25 Transfer From Richard John Rees 0.000p 12,858 £0.00
22-Jul-25 Sell Richard John Rees 14.00p 6,429 £900.06
22-Jul-25 Transfer From Craig Jonathan Gulliford 0.000p 12,858 £0.00
22-Jul-25 Sell Craig Jonathan Gulliford 14.00p 6,429 £900.06

Largest Deals (365 days)

Traded Action Notifier PriceAmountValue
30-May-25 Buy Kevin Crofton 15.75p 701,750 £110,525.62
22-Jul-25 Sell Craig Jonathan Gulliford 14.00p 6,429 £900.06
22-Jul-25 Sell Richard John Rees 14.00p 6,429 £900.06
20-Jan-25 Buy Christopher Paul Hancock 19.10p 4,712 £899.99
16-Jan-25 Buy Craig Jonathan Gulliford 19.10p 4,712 £899.99

Director Shareholdings

Notifier Holding Value*
Kevin Crofton 5,447,416 £578,788
Richard John Rees 2,707,555 £287,678
Craig Jonathan Gulliford 1,679,765 £178,475
Ivonne Cantu 125,000 £13,281

Major Shareholders

Notifier** Holding Value*
M&G Investments 49,583,836 £5,268,283
Canaccord Genuity Group Inc 36,167,753 £3,842,824
Baillie Gifford & Co 27,795,238 £2,953,244
Hargreave Hale Limited 22,846,245 £2,427,414
River Global Investors LLP 20,827,081 £2,212,877
AXA Framlington Investment Managers 17,066,645 £1,813,331
Amati Global Investors 15,959,536 £1,695,701
Development Bank of Wales plc 14,376,727 £1,527,527
Finance Wales 14,376,727 £1,527,527
Creo Medical Group EBT 10,000,000 £1,062,500
The Capital Group Companies, Inc. 8,816,807 £936,786
Tellworth Investments 5,772,778 £613,358
Hoya Corporation 4,799,880 £509,987
Jonathan Craton 3,400,294 £361,281
Cotterford Co Limited 3,335,398 £354,386
Mark Farmer 3,121,607 £331,671
RBC Trustees (CI) Ltd 2,974,727 £316,065
Angel Co Fund 2,967,120 £315,256

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

CREO Market Data

Currency UK Pounds
Share Price 10.63p
Change Today 0.48p
% Change 4.68 %
52 Week High 19.75
52 Week Low 9.55
Volume 827,214
Shares Issued 412.47m
Market Cap £43.83m
Beta 0.52

CREO Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
5.70% above the market average5.70% above the market average5.70% above the market average5.70% above the market average5.70% above the market average
9.09% below the sector average9.09% below the sector average9.09% below the sector average9.09% below the sector average9.09% below the sector average
Price Trend
76.94% below the market average76.94% below the market average76.94% below the market average76.94% below the market average76.94% below the market average
31.43% below the sector average31.43% below the sector average31.43% below the sector average31.43% below the sector average31.43% below the sector average
Income Not Available
Growth
46.91% below the market average46.91% below the market average46.91% below the market average46.91% below the market average46.91% below the market average
65.71% below the sector average65.71% below the sector average65.71% below the sector average65.71% below the sector average65.71% below the sector average

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 1
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

CREO Dividends

No dividends found

Trades for 05-Jan-2026

Time Volume / Share Price
17:07 18,217 @ 10.63p
16:28 200 @ 10.51p
16:21 8,023 @ 10.63p
16:16 3,400 @ 10.62p
16:14 18,217 @ 10.62p

CREO Key Personnel

CEO Craig Jonathan Gulliford
CFO Richard John Rees
Chair Kevin Crofton

Top of Page